Related Experiment Video
Updated: Feb 18, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
A renewed perspective on TCA intermediate cis-aconitate: mechanisms and therapeutic options against influenza virus
Claudia Claus1, Igor Kovacevic2
1Institute of Medical Microbiology and Virology, Medical Faculty, Leipzig University, Leipzig, Germany. claudia.claus@medizin.uni-leipzig.de.
No abstract available in PubMed .
More Related Videos
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Leaky Scanning